Company profile
Galexxy Holdings, Inc.
OTC: GXXY · Healthcare · Drug Manufacturers - Specialty & Generic
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 27
v0.1 · 5/100 weight · pillars only
↑ listing tenure, Piotroski F · ↓ workforce scale, Altman-Z
Methodology →Revenue TTM
$29.2k
Rev growth YoY (TTM)
-95.7%
Net income (FY)
—
Employees
2
as of 2026-10-15
Market cap
$28.4k
as of 2026-10-15
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Galexxy Holdings, Inc.’s financial profile?
Galexxy Holdings, Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Mosaic ImmunoEngineering Inc.——Southern Home Medical, Inc.——China Health Management Corp.——LiveCare, Inc.——Resilient Healthcare Corp——Medical Care Technologies Inc.——Neighbors
Orange →Key facts
CEOMichael Biagi
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersNewport Beach, CA
ExchangeOTC: GXXY
Employees2
IPO date2013-03-21
Latest filings
No filings loaded.
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.